The global obesity-diabetes drugs market is expected to grow moderately due to the increasing number of obese and diabetic patients, particularly in developing countries with rising populations and limited physical activity. The focus on developing new drugs, raising disease awareness,…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.